APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin (IVIg)

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Immunoglobulin (IVIg) Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin (IVIg) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin (IVIg) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin (IVIg) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin (IVIg) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

This report provides an overview of the global Intravenous Immunoglobulin (IVIg) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Intravenous Immunoglobulin (IVIg) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Immunoglobulin (IVIg) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Immunoglobulin (IVIg) market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Immunoglobulin (IVIg) Segment by Company

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Segment by Type

IVIg Liquid

IVIg Powder

Intravenous Immunoglobulin (IVIg) Segment by Application

Immunodeficiency

Autoimmune Disease

Acute Infection

Intravenous Immunoglobulin (IVIg) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Immunoglobulin (IVIg) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Immunoglobulin (IVIg) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Immunoglobulin (IVIg) significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Immunoglobulin (IVIg) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Immunoglobulin (IVIg) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Immunoglobulin (IVIg) industry.

Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Immunoglobulin (IVIg) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Immunoglobulin (IVIg) Industry Trends Table 2. Intravenous Immunoglobulin (IVIg) Industry Drivers Table 3. Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges Table 4. Intravenous Immunoglobulin (IVIg) Industry Restraints Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2021-2026) Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Company (K Bottle) & (2021-2026) Table 8. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Company (2021-2026) Table 10. Global Intravenous Immunoglobulin (IVIg) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Immunoglobulin (IVIg) Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Immunoglobulin (IVIg) Company, Product Type & Application Table 13. Global Intravenous Immunoglobulin (IVIg) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of IVIg Liquid Table 18. Significant Companies of IVIg Powder Table 19. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type 2021 VS 2025 VS 2032 (K Bottle) Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2021-2026) & (K Bottle) Table 21. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2027-2032) & (K Bottle) Table 22. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Type (2021-2026) Table 23. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Type (2027-2032) Table 24. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Type (2021-2026) Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Immunodeficiency Table 30. Significant Companies of Autoimmune Disease Table 31. Significant Companies of Acute Infection Table 32. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application 2021 VS 2025 VS 2032 (K Bottle) Table 33. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2021-2026) & (K Bottle) Table 34. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2027-2032) & (K Bottle) Table 35. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Application (2021-2026) Table 36. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Application (2027-2032) Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Application (2021-2026) Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Application (2027-2032) Table 42. Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032 (K Bottle) Table 43. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2026) & (K Bottle) Table 44. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021-2026) Table 45. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032) & (K Bottle) Table 46. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2027-2032) Table 47. Global Intravenous Immunoglobulin (IVIg) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Region (2021-2026) Table 50. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Region (2027-2032) Table 52. Global Intravenous Immunoglobulin (IVIg) Market Average Price (USD/Bottle) by Region (2021-2026) Table 53. Global Intravenous Immunoglobulin (IVIg) Market Average Price (USD/Bottle) by Region (2027-2032) Table 54. Global Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Table 55. Global Intravenous Immunoglobulin (IVIg) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026) & (K Bottle) Table 57. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021-2026) Table 58. Global Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032) & (K Bottle) Table 59. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2027-2032) Table 60. Global Intravenous Immunoglobulin (IVIg) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Intravenous Immunoglobulin (IVIg) Sales Value Market Share by Country (2021-2026) Table 62. Global Intravenous Immunoglobulin (IVIg) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Intravenous Immunoglobulin (IVIg) Sales Value Market Share by Country (2027-2032) Table 64. Baxter Company Information Table 65. Baxter Business Overview Table 66. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 67. Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio Table 68. Baxter Recent Development Table 69. Grifols Company Information Table 70. Grifols Business Overview Table 71. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 72. Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio Table 73. Grifols Recent Development Table 74. CSL Company Information Table 75. CSL Business Overview Table 76. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 77. CSL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 78. CSL Recent Development Table 79. Octapharma Company Information Table 80. Octapharma Business Overview Table 81. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 82. Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio Table 83. Octapharma Recent Development Table 84. Biotest Company Information Table 85. Biotest Business Overview Table 86. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 87. Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio Table 88. Biotest Recent Development Table 89. Kedrion Company Information Table 90. Kedrion Business Overview Table 91. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 92. Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio Table 93. Kedrion Recent Development Table 94. Hualan Bio Company Information Table 95. Hualan Bio Business Overview Table 96. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 97. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio Table 98. Hualan Bio Recent Development Table 99. CNBG Company Information Table 100. CNBG Business Overview Table 101. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 102. CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio Table 103. CNBG Recent Development Table 104. Shanghai RAAS Company Information Table 105. Shanghai RAAS Business Overview Table 106. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 107. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio Table 108. Shanghai RAAS Recent Development Table 109. CBPO Company Information Table 110. CBPO Business Overview Table 111. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 112. CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio Table 113. CBPO Recent Development Table 114. LFB Group Company Information Table 115. LFB Group Business Overview Table 116. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 117. LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio Table 118. LFB Group Recent Development Table 119. BPL Company Information Table 120. BPL Business Overview Table 121. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 122. BPL Intravenous Immunoglobulin (IVIg) Product Portfolio Table 123. BPL Recent Development Table 124. Sichuan Yuanda Shuyang Company Information Table 125. Sichuan Yuanda Shuyang Business Overview Table 126. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 127. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio Table 128. Sichuan Yuanda Shuyang Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Intravenous Immunoglobulin (IVIg) Distributors List Table 132. Intravenous Immunoglobulin (IVIg) Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin (IVIg) Product Image Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Immunoglobulin (IVIg) Sales (2021-2032) & (K Bottle) Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Average Price (USD/Bottle) & (2021-2032) Figure 6. Global Intravenous Immunoglobulin (IVIg) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. IVIg Liquid Image Figure 10. IVIg Powder Image Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Bottle) Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Type (2021-2032) Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Type (2021-2032) Figure 17. Immunodeficiency Image Figure 18. Autoimmune Disease Image Figure 19. Acute Infection Image Figure 20. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Bottle) Figure 21. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Application (2021-2032) Figure 23. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Intravenous Immunoglobulin (IVIg) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Application (2021-2032) Figure 26. Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032 (K Bottle) Figure 27. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Intravenous Immunoglobulin (IVIg) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Intravenous Immunoglobulin (IVIg) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Intravenous Immunoglobulin (IVIg) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Intravenous Immunoglobulin (IVIg) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Intravenous Immunoglobulin (IVIg) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Intravenous Immunoglobulin (IVIg) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
Companies covered
  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Immunoglobulin (IVIg) Market Dynamics
  1. 2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
  2. 2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
  3. 2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 Intravenous Immunoglobulin (IVIg) Market by Company
  1. 3.1 Global Intravenous Immunoglobulin (IVIg) Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Immunoglobulin (IVIg) Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Immunoglobulin (IVIg) Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Immunoglobulin (IVIg) Company Product Type and Application
  8. 3.8 Global Intravenous Immunoglobulin (IVIg) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Immunoglobulin (IVIg) Market by Type
  1. 4.1 Intravenous Immunoglobulin (IVIg) Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type
  5. 4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Intravenous Immunoglobulin (IVIg) Sales Value by Type
  9. 4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Type (2021-2032)
5 Intravenous Immunoglobulin (IVIg) Market by Application
  1. 5.1 Intravenous Immunoglobulin (IVIg) Application Introduction
  2. 5.1.1 Immunodeficiency
  3. 5.1.2 Autoimmune Disease
  4. 5.1.3 Acute Infection
  5. 5.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application
  6. 5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Immunoglobulin (IVIg) Sales Value by Application
  10. 5.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Value Share by Application (2021-2032)
6 Intravenous Immunoglobulin (IVIg) Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Immunoglobulin (IVIg) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Immunoglobulin (IVIg) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Immunoglobulin (IVIg) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Immunoglobulin (IVIg) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value Share by Country, 2025 VS 2032
7 Intravenous Immunoglobulin (IVIg) Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Immunoglobulin (IVIg) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Immunoglobulin (IVIg) Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Immunoglobulin (IVIg) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Immunoglobulin (IVIg) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Immunoglobulin (IVIg) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Immunoglobulin (IVIg) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
  18. 8.3.5 CSL Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Biotest
  26. 8.5.1 Biotest Company Information
  27. 8.5.2 Biotest Business Overview
  28. 8.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
  30. 8.5.5 Biotest Recent Developments
  31. 8.6 Kedrion
  32. 8.6.1 Kedrion Company Information
  33. 8.6.2 Kedrion Business Overview
  34. 8.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
  36. 8.6.5 Kedrion Recent Developments
  37. 8.7 Hualan Bio
  38. 8.7.1 Hualan Bio Company Information
  39. 8.7.2 Hualan Bio Business Overview
  40. 8.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
  42. 8.7.5 Hualan Bio Recent Developments
  43. 8.8 CNBG
  44. 8.8.1 CNBG Company Information
  45. 8.8.2 CNBG Business Overview
  46. 8.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
  48. 8.8.5 CNBG Recent Developments
  49. 8.9 Shanghai RAAS
  50. 8.9.1 Shanghai RAAS Company Information
  51. 8.9.2 Shanghai RAAS Business Overview
  52. 8.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
  54. 8.9.5 Shanghai RAAS Recent Developments
  55. 8.10 CBPO
  56. 8.10.1 CBPO Company Information
  57. 8.10.2 CBPO Business Overview
  58. 8.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
  60. 8.10.5 CBPO Recent Developments
  61. 8.11 LFB Group
  62. 8.11.1 LFB Group Company Information
  63. 8.11.2 LFB Group Business Overview
  64. 8.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
  66. 8.11.5 LFB Group Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Sichuan Yuanda Shuyang
  74. 8.13.1 Sichuan Yuanda Shuyang Company Information
  75. 8.13.2 Sichuan Yuanda Shuyang Business Overview
  76. 8.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
  78. 8.13.5 Sichuan Yuanda Shuyang Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
  2. 9.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Immunoglobulin (IVIg) Sales Mode & Process
  6. 9.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Immunoglobulin (IVIg) Distributors
  9. 9.2.3 Intravenous Immunoglobulin (IVIg) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst